XML 36 R25.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Combined Balance Sheet as of December 31, 2020 (Tables)

9 Months Ended

Sep. 30, 2021

Unaudited Condensed Combined Balance Sheet As Of December 31 2020

Schedule of Reclassification of Condensed Consolidated Balance Sheet Information

The audited Balance Sheets as of December 31, 2020 of pre-Merger MyMD Florida and Supera is presented below with the adjustments required to eliminate inter-company transactions, implement ASC 842 for reporting leasing transactions and reclassify certain balances to conform with the classification in the Condensed Consolidated Balance Sheet as of September 30, 2021.

MyMD Supera

Pharmaceuticals Pharmaceuticals Restated

Inc. Inc. AJE Total

(audited) (audited) Adjustments # (unaudited)

ASSETS

Current Assets

Cash $ 133,733 $ 14,551 - $ 148,284

Prepaid expenses 1,218 - - 1,218

Due from affiliate - 24,600 (24,600 ) 1 -

Total Current Assets 134,951 39,151 (24,600 ) 149,502

Non-Current Assets

Operating Lease Right-of-Use Assets - - 527,195 3 527,195

Intangible Assets, net - - - -

Total Non-Current Assets - - 527,195 527,195

Total Assets $ 134,951 $ 39,151 $ 502,595 $ 676,697

LIABILITIES

Current Liabilities

Trade and Other Payables $ 1,025,063 $ 556,781 $ 219,885 1,2 $ 1,801,729

Due to Related Party 39,177 - (39,177 ) 2 -

Interest Payable, related party 175,679 - (175,679 ) 2 -

Loan Payable 1,200,000 - - 1,200,000

Operating Lease Payable - - 481,049 3 481,049

Paycheck Protection Program Loan 54,000 16,600 - 70,600

Total Current Liabilities 2,493,919 573,381 486,078 3,553,378

Non-Current Liabilities -

Line of Credit Payable – related party, net of discount 1,734,237 599,747 - 2,333,984

Interest Payable, related party - 29,628 (29,628 ) 2 -

Operating Lease Liability, net of current - - 46,369 3 46,369

Total Non-Current Liabilities 1,734,237 629,375 16,741 2,380,353

Total Liabilities $ 4,228,156 $ 1,202,756 $ 502,819 $ 5,933,731

Commitments and Contingencies

STOCKHOLDERS’ DEFICIT

Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020 4,004 - - 4,004

Additional Paid in Capital 43,411,488 - (1 ) 2 43,411,487

Accumulated Deficit (47,508,697 ) (1,163,605 ) (223 ) 3 (48,672,525 )

Total Stockholders’ Deficit (4,093,205 ) (1,163,605 ) (224 ) (5,257,034 )

Total Liabilities and Stockholders’ Deficit $ 134,951 $ 39,151 $ 502,595 $ 676,697

The following is an explanation of the adjusting entries that were recorded to arrive at the restated Condensed Consolidated Balance Sheet as of December 31, 2020:

AJE #	Account	Debit		Credit
1	Trade and Other Payables		24,600
	Due from Affiliate				24,600
	To eliminate inter-company transactions

2	Due to Related Party		39,177
	Interest Payable, related party		175,679
	Interest Payable, related party		29,628
	Additional Paid-In Capital		1
	Trade and Other Payables				244,485
	To reclassify account balances to conform with the classification on the September 30, 2021 Condensed Consolidated Balance Sheet

3	Operating Lease Right-of-Use		527,195
	Accumulated Deficit		223
	Operating Lease Payable				481,049
	Operating Lease Payable, net of current portion				46,369
	To implement ASC 842 for the accounting of operating leases